Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.150
-0.050 (-2.29%)
Nov 8, 2024, 10:46 AM EST - Market open
Senti Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 0.34 | 2.56 | 4.29 | 2.76 | 0.57 | 0.09 |
Revenue Growth (YoY) | -91.65% | -40.25% | 55.23% | 387.81% | 565.88% | - |
Cost of Revenue | 36.14 | 32.15 | 28.15 | 21.96 | 15.96 | 14.52 |
Gross Profit | -35.81 | -29.59 | -23.86 | -19.2 | -15.39 | -14.44 |
Selling, General & Admin | 25.09 | 34.85 | 38.23 | 21.25 | 9.3 | 7.34 |
Operating Expenses | 25.09 | 34.85 | 38.23 | 21.25 | 9.3 | 7.34 |
Operating Income | -60.9 | -64.44 | -62.08 | -40.45 | -24.69 | -21.78 |
Interest & Investment Income | 1.58 | 2.86 | 1.7 | 0.01 | 0.09 | 0.67 |
Other Non Operating Income (Expenses) | 5.85 | 3.3 | -0.03 | -0.12 | -0.05 | -0.04 |
EBT Excluding Unusual Items | -53.48 | -58.28 | -60.42 | -40.56 | -24.65 | -21.15 |
Asset Writedown | -25.96 | -25.96 | - | -0.02 | -0.24 | -0.01 |
Other Unusual Items | 0.82 | 0.83 | 10.75 | -14.74 | 5.03 | - |
Pretax Income | -78.62 | -83.41 | -49.67 | -55.32 | -19.86 | -21.16 |
Earnings From Continuing Operations | -78.62 | -83.41 | -49.67 | -55.32 | -19.86 | -21.16 |
Earnings From Discontinued Operations | 21.66 | 12.35 | -8.55 | - | - | - |
Net Income | -56.95 | -71.06 | -58.21 | -55.32 | -19.86 | -21.16 |
Net Income to Common | -56.95 | -71.06 | -58.21 | -55.32 | -19.86 | -21.16 |
Shares Outstanding (Basic) | 5 | 4 | 3 | 0 | 1 | 1 |
Shares Outstanding (Diluted) | 5 | 4 | 3 | 0 | 1 | 1 |
Shares Change (YoY) | 2.53% | 69.94% | 796.58% | -78.99% | 2.03% | - |
EPS (Basic) | -12.62 | -16.01 | -22.29 | -189.95 | -14.33 | -15.57 |
EPS (Diluted) | -12.62 | -16.01 | -22.29 | -189.95 | -14.33 | -15.57 |
Free Cash Flow | -44.32 | -64.43 | -76.27 | -40.18 | -25.33 | -20.37 |
Free Cash Flow Per Share | -9.82 | -14.52 | -29.21 | -137.96 | -18.28 | -15.00 |
Operating Margin | -18017.46% | -2516.28% | -1448.53% | -1464.90% | -4362.90% | -25625.88% |
Profit Margin | -16850.00% | -2774.62% | -1358.14% | -2003.59% | -3509.19% | -24890.59% |
Free Cash Flow Margin | -13112.43% | -2515.93% | -1779.51% | -1455.20% | -4475.97% | -23969.41% |
EBITDA | -56.6 | -60.88 | -60.69 | -39.68 | -24.13 | -21.36 |
D&A For EBITDA | 4.3 | 3.56 | 1.4 | 0.77 | 0.56 | 0.43 |
EBIT | -60.9 | -64.44 | -62.08 | -40.45 | -24.69 | -21.78 |
Revenue as Reported | 0.34 | 2.56 | 4.29 | 2.76 | 0.57 | 0.09 |
Source: S&P Capital IQ. Standard template.
Financial Sources.